CAMBRIDGE, Mass.,
Jan. 6, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with
the purpose to better the lives of people impacted by kidney
disease, today announced that John P.
Butler, President and Chief Executive Officer, will
participate in a fireside chat at the H.C. Wainwright Bioconnect
2021 Conference, which takes place virtually January 11 – 14, 2021.
The recorded presentation will be available on the
Investors section of the Company's website at
https://ir.akebia.com beginning Monday, January 11.
About Akebia Therapeutics
Akebia
Therapeutics, Inc. is a fully integrated biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease. The Company was founded in 2007 and is headquartered in
Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Kristen K. Sheppard,
Esq.
ir@akebia.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-hc-wainwright-bioconnect-2021-conference-301201492.html
SOURCE Akebia Therapeutics